Effects of Ozone Therapy on Chronic Arsenic Poisoning in Rats

被引:1
作者
Buyuk, Basak [1 ]
Aydeger, Cemre [2 ]
Oztopuz, Ozlem [3 ]
Ovali, Mehmet Akif [2 ]
Makav, Mustafa [4 ]
Eroglu, Huseyin Avni [2 ]
机构
[1] Izmir Democracy Univ, Fac Med, Dept Histol & Embryol, Izmir, Turkey
[2] Canakkale Onsekiz Mart Univ, Fac Med, Dept Physiol, Terzioglu Campus, TR-17100 Canakkale, Turkey
[3] Canakkale Onsekiz Mart Univ, Fac Med, Dept Biophys, Canakkale, Turkey
[4] Kafkas Univ, Fac Vet Med, Dept Physiol, Kars, Turkey
关键词
Arsenic poisoning; Ozone; Experimental; KIM-1; Liver injury; Renal injury; KIDNEY INJURY MOLECULE-1; INDUCED OXIDATIVE STRESS; MECHANISMS; INFLAMMATION; EXPRESSION; TOXICITY; EXPOSURE; CYSTEINE; ALPHA; MODEL;
D O I
10.1007/s12011-022-03486-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arsenic (As) is a toxic metalloid that affects many organs through drinking water. This study aims to examine the efficacy of ozone therapy on chronic arsenic toxicity. Twenty-four male Wistar albino rats were housed in individual cages and grouped as control, As, O-3, and As + O-3. As was applied by adding 5 mg/kg/day in drinking water for 60 days. Ozone therapy was applied at 0.5 mg/kg/day (i.p.) O-3 in the last 5 days of the experimental period. Tissues were harvested and analyzed for histopathological injury and apoptotic markers. There was no significant difference between the As + O-3 and O-3 groups (p = 0.186 and p = 0.599) for light microscopic criteria: inflammatory cell infiltration and hydropic degeneration in liver tissue. In TUNEL assessments, similar outcomes were obtained in the control and As + O-3 groups. A statistically significant increase was observed in p53 and Caspase 3 (Casp-3) expression levels in the As group compared to the O-3 and As + O-3 groups. There was no significant difference between the As + O-3 and O-3 groups on peritubular hemorrhage and desquamation parameters in kidneys (p = 0.147 and p = 0.094). The KIM-1 expression level was significantly increased in the As group compared to the As + O-3 group (p = 0.01), and the Casp-3 expression level was not significantly changed in the O-3 group compared to the As + O-3 group (p = 0.59). In conclusion, it is determined that ozone therapy has ameliorative effects on the microscopic injury of liver and kidney tissues. In addition to microscopic improvement, KIM-1 gene expression levels were ameliorated in the kidneys. The apoptotic cell counts and the Casp-3 and p53 gene expression levels were decreased by O-3 administration. Thus, ozone therapy can be a treatment choice for As toxicity.
引用
收藏
页码:3951 / 3960
页数:10
相关论文
共 53 条
  • [1] Adali Y., 2020, J HARRAN U MED FAC, V17, P133, DOI [10.35440/hutfd.649302, DOI 10.35440/HUTFD.649302]
  • [2] Efficacy of Ozone and Selenium Therapy for Alcoholic Liver Injury: An Experimental Model
    Adali, Yasemen
    Eroglu, Huseyin Avni
    Makav, Mustafa
    Guvendi, Gulname Findik
    [J]. IN VIVO, 2019, 33 (03): : 763 - 769
  • [3] Arsenic induced apoptosis in rat liver following repeated 60 days exposure
    Bashir, S
    Sharma, Y
    Irshad, M
    Nag, TC
    Tiwari, M
    Kabra, M
    Dogra, TD
    [J]. TOXICOLOGY, 2006, 217 (01) : 63 - 70
  • [4] The Investigation of the Effect of Ozone Therapy on Gout in Experimental Rat Models
    Bilge, Ali
    Tuysuz, Murat
    Ozturk, Omur
    Adali, Yasemen
    Eroglu, Huseyin Avni
    Makav, Mustafa
    Atilla Uslu, Gozde
    Tiskaoglu, Ramazan
    [J]. KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2019, 25 (02) : 245 - 249
  • [5] BOCCI V, 1990, HAEMATOLOGICA, V75, P510
  • [6] Bocci VA, 2006, ARCH MED RES, V37, P425, DOI 10.1016/j.arcmed.2005.08.006
  • [8] Buyuk B, 2019, J SURG MED, DOI [DOI 10.28982/JOSAM.460075, 10.28982/josam.460075]
  • [9] Büyük B, 2020, REV NEFROL DIAL TRAS, V40, P14
  • [10] Ozone therapy prevents renal inflammation and fibrosis in a rat model of acute pyelonephritis
    Caliskan, Bahadir
    Guven, Ahmet
    Ozler, Mehmet
    Cayci, Tuncer
    Ozcan, Ayhan
    Bedir, Orhan
    Surer, Ilhami
    Korkmaz, Ahmet
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2011, 71 (06) : 473 - 480